Compare AU

Compare IXJ vs. QHAL

Compare shares and ETFs on the ASX that you can trade on Pearler.

S&P Global 1200 Healthcare

ASX

Buy

Buy

Overview
Performance

Overview

When it comes to investing in the Australian stock market, shares and ETFs are a popular choice. Two options in the ASX are IXJ and QHAL. In this comparison, we'll delve into these options across various dimensions to help you make an informed investment decision.

Community Stats

IXJ

QHAL

Popularity

Low

Low

Pearlers invested

240

62

Median incremental investment

$1,000.00

$865.83

Median investment frequency

Monthly

Monthly

Median total investment

$1,703.28

$5,068.63

Average age group

26 - 35

> 35


Key Summary

IXJ

QHAL

Strategy

IXJ.AX was created on 2001-11-13 by iShares. The fund's investment portfolio concentrates primarily on health care equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of global biotechnology, healthcare, medical equipment and pharmaceuticals companies and may include large-, mid- or smallcapitalisation stocks

QHAL.AX was created on 2019-03-21 by VanEck. The fund's investment portfolio concentrates primarily on total market equity. QHAL.AX seeks to provide investors with access to a diversified portfolio of quality international companies from developed markets (ex-Australia) hedged into Australian dollars with the aim of providing investment returns, before fees and other costs, which track the performance of the Index.

Top 3 holdings

Eli Lilly and Company (8.25 %)

UnitedHealth Group Incorporated (5.81 %)

Johnson & Johnson (4.72 %)

MSCI Global 'Quality' (ex-AUS hedged) (100 %)

Top 3 industries

Other (99.98 %)

Communication Services (0.02 %)

Top 3 countries

United States (99.97 %)

United States (77.72 %)

Switzerland (4.96 %)

United Kingdom of Great Britain and Northern Ireland (4.17 %)

Management fee

0.46 %

0.43 %


Key Summary

IXJ

QHAL

Issuer

iShares

VanEck

Tracking index

S&P Global 1200 Healthcare Sector Index - AUD

MSCI World ex Australia Quality 100% Hedged to AUD Index - AUD

Asset class

ETF

ETF

Management fee

0.46 %

0.43 %

Price

$141.31

$49.20

Size

$1.380 billion

$1.531 billion

10Y return

129.40 %

N/A

Annual distribution/β€Šdividend yield (5Y)

1.26 %

1.82 %

Market

ASX

ASX

First listed date

11/03/2009

25/03/2019

Purchase fee

$6.50

$6.50


Community Stats

IXJ

QHAL

Popularity

Low

Low

Pearlers invested

240

62

Median incremental investment

$1,000.00

$865.83

Median investment frequency

Monthly

Monthly

Median total investment

$1,703.28

$5,068.63

Average age group

26 - 35

> 35


Pros and Cons

IXJ

QHAL

Pros

  • Higher exposure to US market

  • Lower management fee

  • Higher price growth

  • Higher distribution yield

Cons

  • Higher management fee

  • Lower price growth

  • Lower distribution yield

  • Lower exposure to US market

IXJ

QHAL

Higher exposure to US market

Lower exposure to US market

Higher management fee

Lower management fee

Lower price growth

Higher price growth

Lower distribution yield

Higher distribution yield

Home